Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Active not recruiting 18Recruiting 17Completed 10Not yet recruiting 7Withdrawn 3Unknown 3Terminated 3Suspended 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Biliary Carcinoma 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × zimberelimab × Clear all
NCT06107114 2023-11-22

CZCNRHNSCC

Sun Yat-sen University

Phase 2 Unknown
52 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05540483 2022-09-16

RIGHT

The First Affiliated Hospital with Nanjing Medical University

Phase NA Unknown
31 enrolled
Gastrointestinal

Biliary Carcinoma

NCT03972722 2019-06-05

CC

Guangzhou Gloria Biosciences Co., Ltd.

Phase 2 Unknown
89 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡